Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry
|
May 29, 2018
Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies
Adel S El-Azab, Alaa A-M Abdel-Aziz, Laila A Abou-Zeid, et al.
European Journal of Medicinal Chemistry
|
October 4, 2011
Synthesis and anticonvulsant activity of some new thiazolo[3,2-a][1,3]diazepine, benzo[d]thiazolo[5,2-a][12,6]diazepine and benzo[d]oxazolo[5,2-a][12,6]diazepine analogues
Hussein I El-Subbagh, Ghada S Hassan, Adel S El-Azab, et al.
Molecules (Basel, Switzerland)
|
June 2, 2021
Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking Studies
Abdulmalik S Altamimi, Adel S El-Azab, Sami G Abdelhamid, et al.
Bioorganic Chemistry
|
November 14, 2024
Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4(3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activities
Abdelrahman Hamdi, Samar S Tawfik, Ahmed R Ali, et al.
Bioorganic Chemistry
|
November 1, 2025
Exploiting COX-2 engagement for amplifying anticancer potential of Quinazoline-triazole conjugates with superior EGFR/VEGFR-2 inhibition
Marwa I Serag, Abdelrahman Hamdi, Eman E Nasr, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 27, 2013
Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2
Ibrahim A Al-Suwaidan, Amer M Alanazi, Adel S El-Azab, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 5, 2020
Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study
Alaa A-M Abdel-Aziz, Adel S El-Azab, Nawaf A AlSaif, et al.
European Journal of Medicinal Chemistry
|
July 6, 2010
Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study
Adel S El-Azab, Mohamed A Al-Omar, Alaa A-M Abdel-Aziz, et al.
RSC Advances
|
August 21, 2024
<i>S</i>-Alkylated quinazolin-4(3<i>H</i>)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S Tawfik, Abdelrahman Hamdi, Ahmed R Ali, et al.
Molecular Diversity
|
June 25, 2026
Thiazolidinedione-triazole hybrids: design, synthesis, and biological evaluation as dual inhibitors of α-amylase and aldose reductase with antioxidant activity for antidiabetic therapy
Eman E Nasr, Mohamed R Elnagar, Nahed Nasser Eid El-Sayed, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
Journal of Enzyme Inhibition and Medicinal Chemistry
|
May 29, 2018
Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies
Adel S El-Azab, Alaa A-M Abdel-Aziz, Laila A Abou-Zeid, et al.
European Journal of Medicinal Chemistry
|
October 4, 2011
Synthesis and anticonvulsant activity of some new thiazolo[3,2-a][1,3]diazepine, benzo[d]thiazolo[5,2-a][12,6]diazepine and benzo[d]oxazolo[5,2-a][12,6]diazepine analogues
Hussein I El-Subbagh, Ghada S Hassan, Adel S El-Azab, et al.
Molecules (Basel, Switzerland)
|
June 2, 2021
Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking Studies
Abdulmalik S Altamimi, Adel S El-Azab, Sami G Abdelhamid, et al.
Bioorganic Chemistry
|
November 14, 2024
Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4(3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activities
Abdelrahman Hamdi, Samar S Tawfik, Ahmed R Ali, et al.
Bioorganic Chemistry
|
November 1, 2025
Exploiting COX-2 engagement for amplifying anticancer potential of Quinazoline-triazole conjugates with superior EGFR/VEGFR-2 inhibition
Marwa I Serag, Abdelrahman Hamdi, Eman E Nasr, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 27, 2013
Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2
Ibrahim A Al-Suwaidan, Amer M Alanazi, Adel S El-Azab, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 5, 2020
Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study
Alaa A-M Abdel-Aziz, Adel S El-Azab, Nawaf A AlSaif, et al.
European Journal of Medicinal Chemistry
|
July 6, 2010
Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study
Adel S El-Azab, Mohamed A Al-Omar, Alaa A-M Abdel-Aziz, et al.
RSC Advances
|
August 21, 2024
<i>S</i>-Alkylated quinazolin-4(3<i>H</i>)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S Tawfik, Abdelrahman Hamdi, Ahmed R Ali, et al.
Molecular Diversity
|
June 25, 2026
Thiazolidinedione-triazole hybrids: design, synthesis, and biological evaluation as dual inhibitors of α-amylase and aldose reductase with antioxidant activity for antidiabetic therapy
Eman E Nasr, Mohamed R Elnagar, Nahed Nasser Eid El-Sayed, et al.
Page
of 11